About Forest Our products are principally marketed in the United States and Europe, including Lexapro (escitalopram oxalate) for the treatment of depression and anxiety; Namenda (memantine HCl) for the treatment of moderate to severe Alzheimer's disease; Bystolic (nebivolol) for the treatment of hypertension; and our newest approved product, Savella (milnacipran HCl) for the management of fibromya